Reduce Raw Material Verification Bottlenecks Across Development, Transfer, and Manufacturing
CGT developers and biopharma manufacturers depend on complex raw materials that can influence process performance, product quality, and manufacturing consistency. Yet raw material identity verification is often slow, fragmented, outsourced, or dependent on disconnected analytical workflows that delay development, technology transfer, incoming inspection, and manufacturing decisions.
Biothentix™ provides a standardized, multiplexed approach to raw material identity verification and characterization. With fit-for-purpose reagent kits, automated software analysis, and reproducible workflows on the ArrayView™ platform, Biothentix helps manufacturers generate actionable, traceable raw material data closer to the point of decision.
The result is faster verification, stronger lot and supplier comparability, and a common analytical language that can be shared across suppliers, CDMOs, contract testing laboratories, and internal quality teams.
The Biopharma Challenge
As CGT programs mature, raw material control strategies must evolve from supplier CoA review toward more systematic, phase-appropriate verification. Manufacturers may need to qualify suppliers, compare lots, evaluate formulation changes, support process transfer, investigate unexpected performance shifts, or document material comparability as programs advance toward clinical and commercial manufacturing.
Traditional approaches often rely on supplier Certificates of Analysis, limited functional assays, historical experience, external laboratories, or multiple single-analyte methods. These tools can be useful, but they may not provide timely or sufficient insight when complex biological raw materials contribute to variability.
Where Raw Material Control Creates the Most Pressure
Delays from External Raw Material Verification
Raw material identity verification is often performed by external laboratories or workflows that are not integrated into the manufacturer’s internal decision process. Sample shipment, queue time, testing turnaround, report review, and deviation handling can all delay material-use decisions.
Biothentix can eliminate this bottleneck by enabling standardized, multiplexed raw material verification closer to the point of use.
Limited Control Over Raw Material Quality Testing
Manufacturers own process performance, product quality, regulatory documentation, and risk management, but the data used to evaluate raw material quality often originate from suppliers, CDMOs, CTLs, or methods not designed around the manufacturer’s specific process.
Biothentix gives manufacturers a fit-for-purpose way to define and monitor the raw material attributes that matter most to their process.
Lot-to-Lot Variability Detected Too Late
Complex biological raw materials can vary in ways that are not fully captured by conventional CoA review or limited release testing. When meaningful differences are detected only after a process shift or unexpected performance change, teams may face avoidable troubleshooting and investigation burden.
Biothentix analytical fingerprints can be used to compare incoming lots against qualified references, monitor consistency, and detect meaningful analytical differences before materials enter critical workflows.
Fragmented Methods Across the Supply Chain
Raw material verification becomes harder when suppliers, CDMOs, CTLs, and manufacturers use different methods, specifications, data formats, or interpretation criteria.
Biothentix supports a common analytical language across the raw materials ecosystem. The same kit-defined workflow and analytical fingerprint can be shared across organizations to improve comparability and reduce ambiguity.
Technology Transfer and Scale-Up Risk
As programs move from development to clinical manufacturing, commercial readiness, or a new manufacturing site, raw material control strategies must become more transferable and reproducible..
Biothentix supports technology transfer with standardized workflows, software-defined analysis, and traceable raw material fingerprints that can be implemented consistently across sites and users.
How Biothentix Supports Biopharma Manufacturers: From Reactive QC to Proactive Raw Material Intelligence
Traditional raw material review often asks: “Is this material what we ordered?”
Biothentix enables manufacturers ask more informative questions:
- Does this lot match the material we qualified?
- Is the analytical fingerprint consistent with historical lots?
- Has a supplier or formulation change introduced a measurable difference?
- Are material differences associated with process-development or manufacturing observations?
- Should this material be investigated further using orthogonal or functional methods?
Fit-for-Purpose Kits. Standardized Results.
Biothentix kits are designed around the raw material attributes that matter most to your process, then converted into standardized, software-defined workflows for reproducible testing across sites and users.
Users can define the cytokines, growth factors, enzymes, proteins, or other material attributes most relevant to their process, material, or quality-control strategy. InDevR applies its reagent kit build process to create a fit-for-purpose multiplex kit, with typical build times of less than six weeks.
Once built, the customized kit can be run using the ArrayView™ platform and a standardized workflow, with data automatically analyzed and interpreted by InDevR’s 21 CFR Part 11-ready software.
+1 303-402-9100
6035 Longbow Dr., Suite 102, Boulder, CO, 80301